Detection of von Hippel‐Lindau gene mutation in circulating cell‐free DNA for clear cell renal cell carcinoma

The therapeutic landscape of metastatic clear cell renal cell carcinoma (ccRCC) has rapidly expanded, and there is an urgent need to develop noninvasive biomarkers that can select an optimal therapy or evaluate the response in real time. To evaluate the clinical utility of circulating tumor DNA (ctD...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumiyoshi, Takayuki, Yamasaki, Toshinari, Takeda, Masashi, Mizuno, Kei, Utsunomiya, Noriaki, Sakamoto, Hiromasa, Nakamura, Eijiro, Ogawa, Osamu, Akamatsu, Shusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353948/
https://www.ncbi.nlm.nih.gov/pubmed/34009695
http://dx.doi.org/10.1111/cas.14972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353948/
https://www.ncbi.nlm.nih.gov/pubmed/34009695
http://dx.doi.org/10.1111/cas.14972

Ejemplares similares